Amtolmetin Gaucil in Knee Osteoarthritis

NCT02865161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2016-09-30

No results posted yet for this study

Summary

This study is conducted to study the efficacy and safety of Niselat in patients with osteoarthritis.

Conditions

Interventions

DRUG

NISELAT

NISELAT 600MG BD

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Denisov L Nikolaevich, MD · Moscow, Federal State Budget Scientific Institution "Scientific Research Institute of Rheumatology named VA Nasonova"

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865161 on ClinicalTrials.gov